[1]
“IMMUNOTHERAPY IN HEAD AND NECK CANCER: ADVANCES IN IMMUNE CHECKPOINT INHIBITION AND TARGETED IMMUNOTHERAPIES FOR ENHANCED TREATMENT OUTCOMES”, Med. Ins. J., vol. 2, no. 02, pp. 11–20, Dec. 2024, Accessed: May 09, 2026. [Online]. Available: https://medicalinsights.online/index.php/journal/article/view/26